Korea to vaccinate 12 million against COVID-19 by June, says minister


The decision to temporarily suspend use of the AstraZeneca Covid-19 vaccine was based on new information from Norway that emerged late last night.

No such cases had been found yet in the Netherlands, the Dutch Health Ministry said, adding there was no proof yet of a direct link between the vaccine and the reports from Denmark and Norway.

The World Health Organization, Europe's medicines watchdog, governments and experts have stressed that no causal link has been established between the vaccine and blood clotting and insisted that the shot is safe.

"We are closely reviewing reports but given the large number of doses administered, and the frequency at which blood clots can occur naturally, the evidence available does not suggest the vaccine is the cause", he said.

On Monday, Germany joined Denmark, the Netherlands, Norway, Iceland and Ireland and other countries in suspending the use of the vaccine as it probes the blood clot incidents.

Norwegian officials said on Saturday that the country had "received several adverse event reports about younger vaccinated people with bleeding under the skin" after getting the vaccine shot.

AstraZeneca on Sunday said it had conducted a review covering more than 17 million people vaccinated in the European Union and the United Kingdom which had shown no evidence of an increased risk of blood clots.

As of Wednesday, around five million people in Europe had received the AstraZeneca vaccine.

Irish Health Minister Stephen Donnelly announced his country would suspend doses of the AstraZeneca jab yesterday.

But the various issues mean Astra will only be able to deliver about 100 million doses to the European Union in the first half of the year, it said Friday, about a third of the number originally planned.

32 more COVID-19 cases found on Vancouver Island
But things took a tragic turn after she received her second dose on February 1. Patrick's Day is next week, a day when we often gather with friends", Dr.

In a statement, AstraZeneca said there was no evidence of an increased risk of clotting due to the vaccine. The agency has made no mention of the approval status of the Moderna vaccine.

Australia has secured about 54 million doses of the AstraZeneca vaccine, with the majority to be produced by CSL in Melbourne.

Even as some countries suspend its use, others like the USA are moving to protect their own stockpiles, blocking efforts to redistribute the shot's supply to places with urgent needs. The shots are considered experimental because the vaccines were only developed in the past year, so there is no long-term data for any of them.

The Oxford/AstraZeneca vaccine has been authorised for use in Stri Lanka.

"People die every day, and we have more than 300 million people globally who have been immunized who will die of other causes", said Dr. Mariangela Simao, an assistant director-general at WHO. There have been no reports of patients developing blood clots in the country.

"The vaccine's benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing".

"What the public should be assured of is that the MHRA is a global leader in safety and efficacy of vaccines and is publishing data on side effects on a weekly basis".

Prof McConkey said getting regular exercise is a good way of preventing clots, for people who may have taken the vaccine and are anxious about this latest development.

"Most people over the age of 50 will be vaccinated really within the next few weeks - so it is tremendously successful", he said of the vaccination programme.